Related references
Note: Only part of the references are listed.NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy
Nahed A. Makhlouf et al.
EGYPTIAN LIVER JOURNAL (2021)
Hepatitis C Virus Replication
Keisuke Tabata et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study
Fahimeh Safarnezhad Tameshkel et al.
ARCHIVES OF VIROLOGY (2020)
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4r
Slim Fourati et al.
HEPATOLOGY (2019)
Hepatitis C virus genotype 1 infection: Prevalence of NS5A and NS5B resistance-associated substitutions in naive patients from Argentina
Alfredo P. Martinez et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Nanomedicine as a future therapeutic approach for Hepatitis C virus
Noura H. Abd Ellah et al.
NANOMEDICINE (2019)
Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease
Mohamed A. Mekky et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
Mohamed A. Mekky et al.
INFECTION AND DRUG RESISTANCE (2019)
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
HCV Detection, Discrimination, and Genotyping Technologies
Shrikant Dashrath Warkad et al.
SENSORS (2018)
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt
H. Omar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses
Tania M. Welzel et al.
JOURNAL OF HEPATOLOGY (2017)
Incidence of HCV induced-Esophageal varices in Egypt Valuable knowledge using data mining analysis
Mahmoud Abdel-Aty et al.
MEDICINE (2017)
Prevalence of resistant associated variants (RAVs) in the naive HCV patient candidate for direct acting antiviral (DAA) therapy
Mohammad Hadi Karbalaie Niya et al.
MICROBIAL PATHOGENESIS (2017)
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
Barbara Bartolini et al.
VIRUSES-BASEL (2017)
The Emergence of NS5B Resistance Associated Substitution S282T after Sofosbuvir-Based Treatment
Edward J. Gane et al.
HEPATOLOGY COMMUNICATIONS (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt
A. Elsharkawy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6
Juan Angel Patino-Galindo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients
Minesh Mehta et al.
ARCHIVES OF VIROLOGY (2016)
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
Seyed Moayed Alavian et al.
HEPATITIS MONTHLY (2016)
Host - hepatitis C viral interactions: The role of genetics
Markus H. Heim et al.
JOURNAL OF HEPATOLOGY (2016)
Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis
Helal F. Hetta et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns et al.
LANCET INFECTIOUS DISEASES (2016)
Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy
Enass A. Abdel-Hameed et al.
VIRAL IMMUNOLOGY (2016)
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
Brian J. Kirby et al.
CLINICAL PHARMACOKINETICS (2015)
Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology
Helal F. Hetta et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations
Hezhao Ji et al.
VIROLOGY (2015)
Clinical Evidence and Bioinformatics Characterization of Potential Hepatitis C Virus Resistance Pathways for Sofosbuvir
Eric F. Donaldson et al.
HEPATOLOGY (2015)
Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics
Min Chen et al.
PLOS ONE (2015)
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
R. S. Koff
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource
Donald B. Smith et al.
HEPATOLOGY (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
No detection of the NS5B S282T mutation in treatment-naive genotype 1 HCV/HIV-1 coinfected patients using deep sequencing
Sandra Franco et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Towards realistic estimates of HCV incidence in Egypt
R. Breban et al.
JOURNAL OF VIRAL HEPATITIS (2013)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
Eric Lawitz et al.
LANCET INFECTIOUS DISEASES (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Edward J. Gane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region
Shuang Wu et al.
PLOS ONE (2013)
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
Tarik Asselah et al.
LIVER INTERNATIONAL (2012)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients
Magda Cristina Bernardino Castilho et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
Hepatitis C genotype 4: What we know and what we don't yet know
Sanaa M. Kamal et al.
HEPATOLOGY (2008)
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma
Mohamed Abdel-Hamid et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Share Paper
